Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Zifeng Yang and Qinhai Ma.
Zifeng Yang
Connection Strength
3.795
Qinhai Ma
  1. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. J Ethnopharmacol. 2021 Oct 28; 279:114367.
    View in: PubMed
    Score: 0.953
  2. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-?B) signaling pathway. Phytomedicine. 2020 Nov; 78:153296.
    View in: PubMed
    Score: 0.895
  3. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2. Pharmacol Res. 2020 10; 160:105073.
    View in: PubMed
    Score: 0.891
  4. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-?B signaling pathway. Pharmacol Res. 2020 08; 158:104850.
    View in: PubMed
    Score: 0.880
  5. Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation. Signal Transduct Target Ther. 2021 08 26; 6(1):318.
    View in: PubMed
    Score: 0.060
  6. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues. Int Immunopharmacol. 2021 Jun; 95:107567.
    View in: PubMed
    Score: 0.058
  7. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor. Front Pharmacol. 2020; 11:603830.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.